MedPath

Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention

Not Applicable
Conditions
Pericardial Effusion
Registration Number
NCT01665495
Lead Sponsor
Maria Vittoria Hospital
Brief Summary

The DROP study is a prospective, multi center, randomized, open-label trial to test the efficacy and safety of extended catheter pericardial drainage in patients with non-malignant pericardial effusions.

Detailed Description

The trial will compared the efficacy and safety of pericardiocentesis alone compared with extended pericardial catheter drainage for the prevention of recurrent effusions in patients with non-malignant pericardial effusions requiring intervention.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
122
Inclusion Criteria
  • adult patients
  • pericardial effusion requiring pericardiocentesis
  • non-malignant etiology
Exclusion Criteria
  • known neoplastic etiology
  • known bacterial etiology

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Recurrent pericardial effusion12 months
Need for cardiac surgery12 months
Need for repeated pericardiocentesis12 months
Secondary Outcome Measures
NameTimeMethod
Hospital stay12 months
Disease-related hospitalization12 months
Overall mortality12 months

Trial Locations

Locations (7)

Ospedali Riuniti

🇮🇹

Bergamo, Italy

Ospedale Regionale San Maurizio

🇮🇹

Bolzano, Italy

Ospedale Niguarda

🇮🇹

Milan, Italy

Ospedale degli Infermi

🇮🇹

Rivoli, Italy

Cardiology Department, Maria Vittoria Hospital

🇮🇹

Torino, Italy

Cardiology Department, Ospedale San Giovanni Bosco

🇮🇹

Torino, Italy

Ospedale Mauriziano

🇮🇹

Torino, Italy

Ospedali Riuniti
🇮🇹Bergamo, Italy
Antonio Brucato, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.